Target intelligence / Profile preview

Central neurotransmitter receptors and membrane proteins

Molecular classification
G protein-coupled receptor, Ion channel, Transporter, Receptor
01

Overview

Central neurotransmitter receptors and membrane proteins represent a diverse and extensive group of proteins that facilitate communication within the central nervous system (CNS). This category includes G protein-coupled receptors (GPCRs), ligand-gated ion channels (ionotropic receptors), and various membrane transporters responsible for the uptake and recycling of neurotransmitters (IUPHAR/BPS Guide to PHARMACOLOGY, 2024). These proteins are fundamental to physiological processes such as mood regulation, memory formation, and motor coordination. They function by converting chemical signals—neurotransmitters like glutamate, GABA, dopamine, and serotonin—into electrical or biochemical responses in neurons (StatPearls, 2023). Dysregulation of these systems is implicated in a vast array of conditions, including Alzheimer's disease, schizophrenia, and clinical depression (Purves et al., 2001). While these proteins are the primary targets for many of the most successful drugs in neurology and psychiatry, the term itself is a broad classification rather than a specific molecular entity. Pharmacological interventions targeting these proteins include agonists, antagonists, and reuptake inhibitors designed to modulate synaptic activity. Due to the complexity of the CNS, drugs hitting these targets often face challenges related to blood-brain barrier penetration and off-target effects.

Other names
Neurotransmitter receptorsCNS membrane proteinsSynaptic receptors
02

Mechanism of action

This category encompasses various mechanisms including receptor agonism, antagonism, allosteric modulation, and transport inhibition across multiple distinct protein families.

03

Biological functions

Signal transductionNeurotransmissionSynaptic plasticity
04

Disease associations

Neurodegenerative diseasePsychiatric disordersEpilepsyChronic pain
05

Safety considerations

Central nervous system depressionDependency and withdrawalExtrapyramidal symptomsCognitive impairment
06

Interacting drugs

Diazepam

4 more in the full profile.

07

Biomarkers

Cerebrospinal fluid neurotransmitter metabolitesPositron Emission Tomography (PET) tracer bindingElectroencephalogram (EEG) patterns

Beyond the preview

Go deeper on Central neurotransmitter receptors and membrane proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central neurotransmitter receptors and membrane proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call